Company intelligence / Profile preview
Yangtze River Pharmaceutical Group
- Ownership
- Private
- Employees
- ~16000
- Development stage
- Other
Overview
Yangtze River Pharmaceutical Group is one of China’s largest pharmaceutical companies with over $10 billion in annual revenue. It manufactures more than 300 varieties of pharmaceuticals across chemical drugs, TCMs and biologics. The group has an extensive commercial portfolio as well as a pipeline of innovative investigational drugs—over ten are at different clinical stages—focusing on areas such as oncology and neurology. It also partners internationally to bring biosimilars to the Chinese market through collaborations like that with Alvotech & CCHT Biopharmaceuticals
- Therapeutic areas
- OncologyOphthalmologyImmunologyInfectious Diseases
- Modalities
- Small moleculestraditional Chinese medicinesbiologics including biosimilars and monoclonal antibodies
- Industry
- Pharma
Drug pipeline
23 assets22 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Yangtze River Pharmaceutical Group.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Yangtze River Pharmaceutical Group.